Edwards Lifesciences' deal with JenaValve would limit device access, US FTC says
MLex Summary: The US Federal Trade Commission filed a complaint to block medical device supplier Edwards Lifesciences Corp.’s proposed acquisition of JenaValve Technology Inc. over concerns the acquisition "would limit patient access...To view the full article, register now.
Already a subscriber? Click here to view full article